verve therapeutics stock price prediction
The current price Verve Therapeutics VERV is trading at is 3428 which is within the analysts predicted range. Ad Technical indicators show current momentum could push these 5 stocks even higher.
Find the latest Verve Therapeutics Inc.
. Verve Therapeutics Inc. Ad Our Strong Track Record Has Enabled Us To Become A Leader In Rare Disease. Home Stock Research Reports Stock Forecaster.
Ad Financial Security is Attainable. VERV stocks price has reached 17605 on 2022 July 07 Thursday and it has been dropping for the last year. These 5 companies are set for historic price action.
Ad Our Strong Buys Double the SP. Your Connection to Timely Investment Insights for Institutional Investors. Shares of Verve Therapeutics Inc.
About the Verve Therapeutics Inc stock forecast. View Verve Therapeutics Inc VERV investment stock information. VERV stock forecast Our latest prediction for Verve Therapeutics Incs stock price was made on the July 15 2022 when the stock price was at 2371.
Find a Dedicated Financial Advisor Now. The Score for VERV is 32 which is 36 below its historic median score of 50 and infers higher risk than normal. Close price at the end of the last trading day Friday 7th Jan 2022 of the VERV stock was 3205.
Featuring AI generated news summaries. Latest Verve Therapeutics Inc VERV stock forecast price target and predictions from top institutional analysts. What is VERVs Earnings Per Share EPS.
The average Verve Therapeutics stock price prediction forecasts a potential upside of 7121 from the current VERV share price of 3115. Verve Therapeutics VERV adaptive stock price forecast ideologically balanced news. Browse analyst ratings and price targets on all stocks.
Verve Therapeutics stock forecast analyst price target predictions based on 6 analysts offering 12-months price targets for VERV in the last 3 months. Ad Get Access to Our In-Depth Global Research on Equities Fixed Income and the Economy. Find the historical stock prices of Verve Therapeutics Inc.
VERV IEX Real-Time Price USD 3115-394 -1123 At. The current Verve Therapeutics VERV share price is 3563. Based On Fundamental Analysis.
Stock USD 1526 024 155 Verve Therapeutics stock price prediction is an act of determining the future value of Verve Therapeutics shares using few different conventional. Our Suite of Platforms isnt Just Made For the Trading Obsessed - its Made by Them. Discover Which Investments Align with Your Financial Goals.
Find a Dedicated Financial Advisor Now. Discover the Power of thinkorswim Today. Machine learning powered price prediction.
VERV stock quote history news and other vital information to help you with your stock trading and investing. As of 2022 September 13 Tuesday current price of VERV stock is 38470 and our data indicates that the asset price has been in a. Verve Therapeutics Inc stock price forecast for further price development down to -110 time horizon.
The price of the Verve Therapeutics Inc stock has been. We Are Well Positioned to Deliver Sustainable Top-Tier Growth Enhanced Shareholder Value. In the short term.
NASDAQVERV Get Rating traded up 68 during mid-day trading on Tuesday. Pontoon boat trailer rental near Birobidzhan Jewish Autonomous Oblast monroe county wi obituaries. 1 day and price target of 3470 USD.
The stock traded as high as 3419 and last traded. This is 11 more than the trading day before Thursday 6th Jan 2022. Discover Which Investments Align with Your Financial Goals.
Get the latest Verve Therapeutics Inc VERV detailed stock quotes stock data Real-Time ECN. Now is the time to move. Ad Financial Security is Attainable.
Verve Therapeutics Protecting The World From Heart Disease
Why Verve Therapeutics Stock Crushed It This Week The Motley Fool
Verve Therapeutics Inc Verv Stock Price Quote News Stock Analysis
Verve Therapeutics A Gene Editing Crispr Company Focused On Curing Heart Disease Files For Ipo R Biotechplays
Verve Therapeutics Stock Nasdaq Verv Quotes And News Summary Benzinga
Verve Therapeutics Verv Presents At The Tides Usa Annual Event Slideshow Nasdaq Verv Seeking Alpha
Verve Therapeutics Cathie Wood Adds To Arkk Nasdaq Verv Seeking Alpha
Verve Therapeutics Inc Verv Stock Price Quote News Stock Analysis
Verve Ceo Interview Gene Editing For Heart Disease New Data
Verve Therapeutics Inc Verv Stock Price News Info The Motley Fool
Verve Therapeutics Inc Verv Stock Price Quote News Stock Analysis
Verve Therapeutics Prepares 201 Million Ipo Pending Verv Seeking Alpha
Swerve Into Verv R Wallstreetbets
Verve Therapeutics Inc Verv Stock Price Quote News Stock Analysis
Cathie Wood Bets Big On These 2 Strong Buy Stocks Nasdaq
Verve Therapeutics Doses First Patient With In Vivo Base Editing Therapy